Jefferies Group LLC Alector, Inc. Transaction History

Jefferies Group LLC

  • $10.2 Billion
  • Q3 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$8.19 - $13.2 $80,163 - $129,201
-9,788 Reduced 33.01%
19,868 $11,000
Q2 2022

Aug 15, 2022
BUY
$7.65 - $14.24 $226,868 - $422,301
29,656 New
29,656 $43,000
Q4 2019

Feb 13, 2020
SELL
$14.17 - $20.3 $392,509 - $562,310
-27,700 Closed
0 $0
Q3 2019

Nov 13, 2019
BUY
$14.42 - $22.2 $399,434 - $614,940
27,700 New
27,700 $399,000

Others Institutions Holding ALEC

# of Institutions
161
Shares Held
59.8M
Call Options Held
67.8K
Put Options Held
200
View Full List

About Alector, Inc.

ALEC Quotes by TradingView
  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $358M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email